EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

The Effect of Vitamin D Deficiency Treatment on Hemoglobin Levels in Hemodialysis Patients: A Double-blind, Randomized Controlled Trial

Seyede Fatemeh Ghasemian, Shahla Ahmadi Halili, Fatemeh Hayati, Seyed Seifollah Beladi-Mousavi, Shokouh Shayanpour, Leila Sabetnia

Jundishapur Journal of Chronic Disease Care · 2022

DOI: 10.5812/jjcdc-119008 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Jundishapur Journal of Chronic Disease Care, 2022. Verfasst von Seyede Fatemeh Ghasemian und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The role of vitamin D deficiency and hemoglobin levels in renal anemia is well established. However, few studies with inconsistent findings have examined the relationship between vitamin D supplementation and the prevalence and severity of anemia in the chronic kidney disease.

Objectives

The present study aimed to evaluate the effect of vitamin D deficiency treatment on hemoglobin levels in hemodialysis patients.

Methods

The present study was a double-blind, randomized controlled trial on 60 hemodialysis patients aged 18 - 83 years, who were undergoing maintenance dialysis and receiving erythropoietin. All patients with vitamin D (< 30 ng/mL) referred to the dialysis wards of Imam Khomeini, Razi, and Sina hospitals in Ahvaz in 2019, were assigned into two groups. One group was treated with 500 mg oral calcium-D tablets three times a day, and another group was treated with 50,000 units of D-Pearls weekly. The two groups were treated for 12 weeks. Then they were re-evaluated in terms of response to treatment and the rate of improvement in hemoglobin levels and erythropoietin dose.

Results

In each intervention group, vitamin D levels increased significantly (P < 0.001). D-Pearls improved vitamin D deficiency; however, the difference was not statistically significant. This study also showed a significant increase in hemoglobin (> 1 unit) in the calcium-D group; however, such a change was not observed in the D-Pearls group (P = 0.3824). Moreover, there was no difference between the two groups in terms of erythropoietin dose (P = 0.98), blood calcium level (P = 0.57), parathyroid level (P = 0.20), and phosphorus (P = 0.99).

Conclusions

Despite its significant limitations,this study revealed vitamin D supplements improved vitamin D deficincy, and calcium-D tablets could improve hemoglobin levels in patient.

Zitieren

APA

Ghasemian, S. F., Halili, S. A., Hayati, F., Beladi-Mousavi, S. S., Shayanpour, S., & Sabetnia, L. (2022). The Effect of Vitamin D Deficiency Treatment on Hemoglobin Levels in Hemodialysis Patients: A Double-blind, Randomized Controlled Trial. Jundishapur Journal of Chronic Disease Care. https://doi.org/10.5812/jjcdc-119008

Vancouver

Ghasemian SF, Halili SA, Hayati F, Beladi-Mousavi SS, Shayanpour S, Sabetnia L. The Effect of Vitamin D Deficiency Treatment on Hemoglobin Levels in Hemodialysis Patients: A Double-blind, Randomized Controlled Trial. Jundishapur Journal of Chronic Disease Care. 2022. doi:10.5812/jjcdc-119008

BibTeX
@article{Ghasemian2022,
  author = {Ghasemian, Seyede Fatemeh and Halili, Shahla Ahmadi and Hayati, Fatemeh and Beladi-Mousavi, Seyed Seifollah and Shayanpour, Shokouh and Sabetnia, Leila},
  title = {The Effect of Vitamin D Deficiency Treatment on Hemoglobin Levels in Hemodialysis Patients: A Double-blind, Randomized Controlled Trial},
  journal = {Jundishapur Journal of Chronic Disease Care},
  year = {2022},
  doi = {10.5812/jjcdc-119008}
}
Kostenlos starten →